IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis

R. B. Fick, R. S. Baltimore, S. U. Squier, Herbert Reynolds

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

To study how fragmented IgG antibodies might arise within the respiratory secretions of individuals with cystic fibrosis (CF), we screened protease extracts from CF polymorphonuclear leukocytes and mucoid and nonmucoid transformants of Pseudomonas aeruginosa from patients with CF for IgG proteolytic activity. All strains of P. aeruginosa tested exhibited IgG proteolytic activity. Incubation for 7 hr at 37 C was required to demonstrate generation of free Fcγ immunoreactivity. Further analysis of these cleavage products of CF IgG demonstrated generation of Fcγ polypeptides with 4S sedimentation coefficients and F(ab')2 fragments with 5S coefficients. Bacterial IgG proteolytic activity was inhibited by EDTA and was associated with levels of bacterial elastase exceeding 5 μg/mg of total protein. Pseudomonas elastase was signigicantly more active on IgG1 and IgG3; IgG2 and IgG4 were more resistant. This bacterial exoproduct appears to digest IgG molecules into Fabγ, F(ab')2 fragments, and a free Fcγ piece with a molecular weight of 40,000.

Original languageEnglish (US)
Pages (from-to)589-598
Number of pages10
JournalJournal of Infectious Diseases
Volume151
Issue number4
DOIs
StatePublished - Jan 1 1985

Fingerprint

Cystic Fibrosis
Pseudomonas aeruginosa
Immunoglobulin G
Pancreatic Elastase
Pseudomonas
Edetic Acid
Neutrophils
Peptide Hydrolases
Molecular Weight
Peptides
Antibodies

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Fick, R. B. ; Baltimore, R. S. ; Squier, S. U. ; Reynolds, Herbert. / IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis. In: Journal of Infectious Diseases. 1985 ; Vol. 151, No. 4. pp. 589-598.
@article{bb10ab07903849d9b00e564b9bfaa1c3,
title = "IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis",
abstract = "To study how fragmented IgG antibodies might arise within the respiratory secretions of individuals with cystic fibrosis (CF), we screened protease extracts from CF polymorphonuclear leukocytes and mucoid and nonmucoid transformants of Pseudomonas aeruginosa from patients with CF for IgG proteolytic activity. All strains of P. aeruginosa tested exhibited IgG proteolytic activity. Incubation for 7 hr at 37 C was required to demonstrate generation of free Fcγ immunoreactivity. Further analysis of these cleavage products of CF IgG demonstrated generation of Fcγ polypeptides with 4S sedimentation coefficients and F(ab')2 fragments with 5S coefficients. Bacterial IgG proteolytic activity was inhibited by EDTA and was associated with levels of bacterial elastase exceeding 5 μg/mg of total protein. Pseudomonas elastase was signigicantly more active on IgG1 and IgG3; IgG2 and IgG4 were more resistant. This bacterial exoproduct appears to digest IgG molecules into Fabγ, F(ab')2 fragments, and a free Fcγ piece with a molecular weight of 40,000.",
author = "Fick, {R. B.} and Baltimore, {R. S.} and Squier, {S. U.} and Herbert Reynolds",
year = "1985",
month = "1",
day = "1",
doi = "10.1093/infdis/151.4.589",
language = "English (US)",
volume = "151",
pages = "589--598",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "4",

}

IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis. / Fick, R. B.; Baltimore, R. S.; Squier, S. U.; Reynolds, Herbert.

In: Journal of Infectious Diseases, Vol. 151, No. 4, 01.01.1985, p. 589-598.

Research output: Contribution to journalArticle

TY - JOUR

T1 - IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis

AU - Fick, R. B.

AU - Baltimore, R. S.

AU - Squier, S. U.

AU - Reynolds, Herbert

PY - 1985/1/1

Y1 - 1985/1/1

N2 - To study how fragmented IgG antibodies might arise within the respiratory secretions of individuals with cystic fibrosis (CF), we screened protease extracts from CF polymorphonuclear leukocytes and mucoid and nonmucoid transformants of Pseudomonas aeruginosa from patients with CF for IgG proteolytic activity. All strains of P. aeruginosa tested exhibited IgG proteolytic activity. Incubation for 7 hr at 37 C was required to demonstrate generation of free Fcγ immunoreactivity. Further analysis of these cleavage products of CF IgG demonstrated generation of Fcγ polypeptides with 4S sedimentation coefficients and F(ab')2 fragments with 5S coefficients. Bacterial IgG proteolytic activity was inhibited by EDTA and was associated with levels of bacterial elastase exceeding 5 μg/mg of total protein. Pseudomonas elastase was signigicantly more active on IgG1 and IgG3; IgG2 and IgG4 were more resistant. This bacterial exoproduct appears to digest IgG molecules into Fabγ, F(ab')2 fragments, and a free Fcγ piece with a molecular weight of 40,000.

AB - To study how fragmented IgG antibodies might arise within the respiratory secretions of individuals with cystic fibrosis (CF), we screened protease extracts from CF polymorphonuclear leukocytes and mucoid and nonmucoid transformants of Pseudomonas aeruginosa from patients with CF for IgG proteolytic activity. All strains of P. aeruginosa tested exhibited IgG proteolytic activity. Incubation for 7 hr at 37 C was required to demonstrate generation of free Fcγ immunoreactivity. Further analysis of these cleavage products of CF IgG demonstrated generation of Fcγ polypeptides with 4S sedimentation coefficients and F(ab')2 fragments with 5S coefficients. Bacterial IgG proteolytic activity was inhibited by EDTA and was associated with levels of bacterial elastase exceeding 5 μg/mg of total protein. Pseudomonas elastase was signigicantly more active on IgG1 and IgG3; IgG2 and IgG4 were more resistant. This bacterial exoproduct appears to digest IgG molecules into Fabγ, F(ab')2 fragments, and a free Fcγ piece with a molecular weight of 40,000.

UR - http://www.scopus.com/inward/record.url?scp=0021912870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021912870&partnerID=8YFLogxK

U2 - 10.1093/infdis/151.4.589

DO - 10.1093/infdis/151.4.589

M3 - Article

VL - 151

SP - 589

EP - 598

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 4

ER -